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supports use of procalcitonin in the emergency
room for diagnosis of severe sepsis
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Background: Given the acknowledged problems in sepsis diagnosis, we use a novel way with the application of
the latent class analysis (LCA) to determine the operative characteristics of C-reactive protein (CRP), D-dimer (DD)
and Procalcitonin (PCT) as diagnostic tests for sepsis in patients admitted to hospital care with a presumptive
infection.
Methods: Cross-sectional study to determine the diagnostic accuracy of three biological markers against the gold
standard of clinical definition of sepsis provided by an expert committee, and also against the likelihood of sepsis
according to LCA. Patients were recruited in the emergency room within 24 hours of hospitalization and were
follow-up daily until discharge.
Results: Among 765 patients, the expert committee classified 505 patients (66%) with sepsis, 112 (15%) with
infection but without sepsis and 148 (19%) without infection. The best cut-offs points for CRP, DD, and PCT were
7.8 mg/dl, 1616 ng/ml and 0.3 ng/ml, respectively; but, neither sensitivity nor specificity reach 70% for any
biomarker. The LCA analysis with the same three tests identified a “cluster” of 187 patients with several
characteristics suggesting a more severe condition as well as better microbiological confirmation. Assuming this
subset of patients as the new prevalence of sepsis, the ROC curve analysis identified new cut-off points for the tests
and suggesting a better discriminatory ability for PCT with a value of 2 ng/ml.
Conclusions: Under a “classical” definition of sepsis three typical biomarkers (CRP, PCT and DD) are not capable
enough to differentiate septic from non-septic patients in the ER. However, a higher level of PCT discriminates a
selected group of patients with severe sepsis.
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Sepsis is defined as the host response to infection and it
is an important cause of morbidity and mortality around
the world [1,2]. The surviving sepsis campaign issued a
call for global action against sepsis and pointed out diag-
nosis as a fundamental challenge [3,4]. In early stages of
the process, the source of infection may be unclear and
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reproduction in any medium, provided the orinfectious diseases. Consequently, clinicians often miss
or delay this diagnosis. This is especially worrying; since
there is strong evidence supporting that early treatment
is associated with greater clinical success [5]. An ideal
“Gold Standard” is not available for sepsis diagnosis, as
microbiology is not enough sensitive and laboratory tests
are not specific for using as reference standards. The
lack of any reference standard has been overcome by
using techniques that avoid the need for comparison
with a single accurate test. These techniques can be
broadly divided into latent class analysis (LCA) and
Bayesian analysis [6]. LCA has been used widely inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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not been yet applied to the evaluation of sepsis.
On the other hand, sepsis is associated with the simul-
taneous activation of the inflammatory and coagulation
cascades, and most of their components are markers or
mediators in the host response [12,13]. From this close
interplay between inflammation and coagulation, which is
a recognized way toward organ dysfunction and mortality
[14], emerges the rationale to characterize the host re-
sponse to infection. Three potential biomarkers have shown
regular presence in systemic infections: C-reactive protein
(CRP), procalcitonin (PCT), and D-dimer (DD); the latter
as an unspecific signal of coagulation activation [15-19].
So far, however, no large prospective studies support any
of them as a single independent criterion for sepsis. We
aimed to estimate the diagnostic accuracy of these three
biomarkers as diagnostic tests for sepsis, with the applica-
tion of the latent class analysis, in patients at the ER ad-
mittance with a presumptive infection as main diagnosis.Methods
Prospective single center study on the diagnostic accuracy
of a test. The study protocol and a pre-specified nested
analysis were previously published [20,21].Setting
Emergency Room (ER) at the “Hospital Universitario
San Vicente de Paúl” (Medellín, Colombia). This is a
550-bed, fourth level University Hospital with an admis-
sion rate of approximately 1800 patients per month
through the ER and is a reference institution for a region
including approximately 3 million habitants.Subjects
Inclusion criteria: 1. Patients hospitalized in the ER within
24 hours before admission to the study. 2. Aged 18 years
or older. 3. At least one of the following causes as the main
admission diagnosis to the hospital: a) any kind of in-
fectious disease (confirmed or suspected), b) fever of un-
known origin, c) delirium or any kind of encephalopathy of
unknown origin or d) acute hypotension not explained by
hemorrhage, myocardial infarction, stroke or heart failure.
We selected these relatively broad criteria according with
the last consensus conference on sepsis definitions [22].
Exclusion criteria: 1. Negative of the patients, their fam-
ilies, or the attending physician to be part of the study.
2. Antimicrobial treatment received at another medical
institution immediately before admission to the study.
3. Medical decision to treat the patient ambulatory or in
a different institution within 24 hours after admission.
4. Homeless or inability of the patient to follow up. 5. Pre-
vious participation in the same study.Recruitment and data collection
We obtained approval for the study from the ethics
committee of the Medical Research Centre (University of
Antioquia) and the recruited patients provided informed
consent. Three physicians (FJ, GDLR, or MLV) and two
trained nurses recruited patients by checking admission
lists and clinical records and collected data daily from
Monday to Saturday of each week. The general protocol for
each patient was [20]: collection of baseline clinical data,
calculation of entrance Sepsis-related Organ Failure Assess-
ment (SOFA) score [23] and Acute Physiology and Chronic
Health Evaluation (APACHE II) score [24] and blood sam-
pling, all of these procedures performed within the first
24 hours of ER admission. During the first 7 days of hos-
pital stay, additionally, the patients were monitored with
daily recording of any relevant data registered in medical or
nurse records, using a standardized case report form.
Study tests
CRP, PCT and DD were measured in all patients twice: at
admission to the study and on the next day morning (i.e.,
within 24 hours after the first sample). Serum samples for
PCT and CRP were collected in a dry tube with gel separ-
ator and centrifuged within the first 2 hours. PCT con-
centrations were measured by an immunoluminometric
assay (VIDAS® B•R•A•H•M•S PCT, Biomeriux, France).
CRP was measured quantitatively by an immunotur-
bidimetric assay using an ARCHITECT® c-System (Abbott
Laboratories®, USA). Samples for DD were collected in a
tube containing citrate as anticoagulant and processed
within 2 hours. DD (ng/ml) was measured by a turbidi-
metric immunoassay in an ACL Elite® coagulometer using
a Hemosil™ kit (Instrumentation Laboratory, MA, USA).
All previous assays were conducted at the hospital labora-
tory by trained personnel, under the institution technical
standards, and who had no knowledge of the clinical sta-
tus of the patients, nor the study objectives.
Gold standards
Clinical gold standard: we used an expert consensus
based on clinical, microbiologic, laboratory, and radio-
logic data collected for each patient during the first
7 days of hospitalization. The experts also took into ac-
count the definitions stated in 2001 at the International
Sepsis Definitions Conference [22] as well as the Centers
for Disease Control and Prevention (CDC) definitions
for infection [25]. The consensus was formed by a panel
of three physicians with certified training and expertise
in intensive care (AG), internal medicine (CMA), and in-
fectious diseases (CIG). First, each physician established
a diagnosis individually, in which they agreed on 65% of
the cases. The remaining 35% of the patients were fully
discussed to determine a final diagnosis. All the experts
were blinded to the results of CRP, PCT and DD. The
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fected, infected without sepsis and sepsis groups.
Likelihood of sepsis in the study population according
to a LCA: this analysis postulates the existence of an un-
observed categorical variable that divides the population
of interest into classes. Members of the population with a
set of observed variables will respond differently depend-
ing on the latent class (variable) to which they belong. The
problem that the outcome of interest cannot be measured
directly occurs in many research situations. Examples in-
clude constructs such as intelligence, personality traits or,
as in our case, the true sepsis diagnosis. These unobserv-
able outcomes, named also latent variables, can only be
measured indirectly by eliciting responses that are related
to the construct of interest. These measurable responses
are called indicators or manifest variables. Latent variable
models are a group of methods that use the information
from the manifest variables to identify subtypes of cases
defined by the latent variable. The classification appears
by modeling the relationship between manifest (CRP, PCT
and DD) and latent (sepsis/ no sepsis) variables in such a
way that the parameters of interest (prevalence, sensitivity,
specificity) are estimable from the implied relations be-
tween observable variables. In other words, LCA is just a
mathematical model that identifies a subtype or a cluster
of observations according to certain defined characteristics
or variables that are common to those observations. In
this case, we know that different expressions of inflamma-
tion and coagulation are common responses in the process
of infection. Therefore, we provided these observed vari-
ables (DD, PCT and CRP) from all the study population to
the model and it is able to uncover the hidden group, i.e.
the latent variable, to which the patients belong. In sum-
mary, the goal of latent class analysis is to use the ob-
served probabilities to estimate the unobserved ones.
Sample size and analysis plan
The number of the patients with the disease (ND) that is
needed to give a sensitivity of 95%, with a 95% CI +/−
3%, is calculated with the following formula [26]:
ND ¼ Z
2 a=2  sensitivity 1‐sensitivityð Þ
0; 03 2ð Þ2
ND ¼ 1; 96
2  0; 95 0; 05ð Þ
0; 06ð Þ2 ¼ 203
The ND is also determined by the prevalence (P) of
the disease. Hence, the total of patients (TP) required is:
TP¼ND
P
We expected a prevalence of sepsis of 30% [2,21], and
the sample size would be 700 participants.Clinical gold standard: the cut points for the study
tests were determined using receiver operative charac-
teristics (ROC) curves [27], searching for the best sensi-
tivity and specificity. The method based in the Bayes’
theorem was used to determine the operating character-
istics of the tests. Additional analyses were done using
changes of the values in the first 24 hours (Δ24) for each
test and combining pairs of tests (PCT/DD and CRP/
DD). For a Δ24 test, it was considered positive in a pa-
tient if her values remain without changes or increase.
For combining pair of tests, it was considered positive if
both biomarkers were above the cut point. Furthermore,
as a sensitivity analysis, two alternative reference stan-
dards for sepsis patients were considered: only those
who had any microbiologically confirmed infection and
only those who were diagnosed as sepsis patients inde-
pendently by one of the experts (65% among the total
population). Patients with missing values were excluded
for the corresponding analysis, and results are shown
with exact 95% CI using STATA SE (Version 10, Stata
Corp, College Station, TX).
LCA: it assumes that results from the three tests in the
same subject are independent within the real condition of
illness [7]. In other words, if the effect to belong to a latent
condition of sepsis would be removed, the effects to the
CRP, PCT and DD would have a completely random distri-
bution in the study population. Since that both PCT and
CRP values are probably a common expression of the same
inflammatory process, we controlled this local independ-
ence assumption introducing a random effect through a
continuous latent variable [20]. The maximum likelihood
estimators of prevalence (the “cluster” of sepsis patients), as
well as of sensitivity and specificity of each test if requested,
are obtained with an integral that uses an EM iteration al-
gorithm. Analyses were carried out with LATENTGOLD
4.0 (Statistical Innovations, Belmont, MA, USA).
Results
Enrollment began on August 2007 and concluded on
February 2009. A total of 1,795 patients were eligible and
1,030 were excluded, most of them because of more than
24 hours of hospitalization before recruitment and refusal
to participate (Figure 1). Among 765 patients included, 683
(89%) had a suspected infection as admission diagnosis,
56 (7%) fever of unknown cause, 20 (3%) delirium or en-
cephalopathy of unknown origin, and 6 (1%) unexplained
hypotension. There were 377 males (49%), the mean age
was 51.4 years (SD = 20), and the median time of symp-
toms before consultation was 72 hours (IQR = 24 to192
hours). There was no comorbidity in 307 (40%) of the par-
ticipants, and the most frequent previous diseases were
diabetes mellitus (n= 146, 19%), chronic obstructive pul-
monary disease (n = 94, 12%), chronic renal failure (n = 88,
11%), use of corticosteroids or chemotherapy during the
Figure 1 Flow chart of recruitment, patients’ classification by expert consensus and biomarker results. The values of biomarkers are
presented as number of samples measured, median and interquartile range (IQR). CRP = C-reactive protein (mg/dL), DD = D-dimer (ng/ml),
PCT = Procalcitonin (ng/ml), Δ24 =Measurement 2 - Measurement 1.
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previous month (n = 53, 7%). As suspected sources of in-
fection, the most frequent were respiratory (n = 179, 23%)
and skin and soft tissues (n = 174, 23%), followed by urin-
ary tract (n = 127, 17%), intrabdominal (n = 93, 12%), un-
determined (n = 94, 12%) and others (n = 96, 13%). The
median SOFA and APACHE II score were 2 (IQR = 1-4)
and 9 (IQR = 5-14), respectively, hospital length of stay was
9 days (IQR = 5 to 17 days), ICU admission was required
in 66 patients (9%) and the overall 28-day mortality rate
was 12% (n = 91). Due to logistic or technical reasons CRP,DD and PCT at admission were measured in748 (98%),
744 (97%) and 747 (98%) patients, respectively. The median
and IQR values for these test were CRP = 9.4 mg/dl (3.5-
20), DD= 1673 ng/ml (982–1841) and PCT = 0.4 ng/ml
(0.1-3.65).
According to the expert committee 505 patients (66%)
were classified with sepsis, 112 (15%) with infection but
without sepsis and 148 (19%) without infection. The
kappa-statistic measure for multi-rater agreement be-
tween experts was 0.65 for sepsis-no sepsis and 0.73 for
infection with and without sepsis. Figure 1 shows this
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Table 1 shows the main characteristics by group. Among
infected patients (with and without sepsis, n = 617) a mi-
crobiologic diagnosis was confirmed in 104 patients (17%)
by blood culture, in 135 (22%) by urinary culture and in
145 (26%) by other samples. Microorganisms isolated in
blood were E. coli (n = 29, 28%), S. aureus (n = 17, 16%),
coagulase-negative staphylococci (n = 15, 14%) and others
(n = 43, 42%); and in urine were E. coli (n = 79, 59%), K.
pneumoniae (n = 22, 16%) and others (n = 34, 25%). The
main admission diagnosis in the sepsis group (n = 505)
was community-acquired pneumonia (n = 115, 23%), fol-
lowed by urinary tract infection (n = 87, 17%) and soft tis-
sue infection (n = 79, 16%).The main alternative diagnosis
in 148 patients without infection were cancer (n = 22,15%),
chronic obstructive pulmonary disease (n = 15, 10%), acute
pulmonary edema (n = 13, 9%), metabolic diseases (n = 13,
9%), biliary diseases (n = 10, 7%), and others (n = 75, 50%).Table 1 Clinical characteristics at admission according to the
Clinical Sepsis Infe
characteristics n = 505
SOFA score 3 (2–4, 505)
APACHE II score 10 (6–16, 505)
Temperature (°C) 37 (36.5 - 38, 472) 3
Heart rate 100 (87–115, 493)
Respiratory rate 22 (20–28, 121)
MAP 104 (91–120, 493) 1
WBC (cells/mm3) 12900 (8900–17900, 500) 945
Neutrophils (%) 82 (74–89, 500)
Hemoglobin (g/dl) 12 (11–14, 500)
Creatinin (mg/dl) 1 (0.8 – 1.9, 500)
Lactic Acid (mmol/L) 1.9 (1.2 – 2.9, 494)
Bilirrubin (mg/dl) 0.7 (0.5 – 1.1, 494)
PaO2/FiO2 304.5 (212–364, 492) 3
Suspected source of infection
Respiratory 120 (24%)
Urinary tract 93 (18%)








28-day mortality rate 68 (13.5%)
The values are expressed as median (IQR, Observations available) or number (perce
obstructive pulmonary disease, CRF, Chronic renal failure.
*Kruskal-Wallis for continuous variables and Chi-square for proportions.According to the ROC curve analysis, the cut-offs points
with the best sensitivity and specificity for CRP, DD, and
PCT to discriminate at admission between sepsis and not
sepsis (infection without sepsis or not infection) were
7.8 mg/dl, 1616 ng/ml, and 0.3 ng/ml, respectively. Their
operating characteristics, at both measurement times, are
shown in Table 2. Analyses combining pairs of tests or
using changes in the first 24 hours (Δ24) did not show
any improvement in diagnostic accuracy. Similar results
were seen using the alternative reference standards (data
no shown).
The LCA analysis with the same three tests identified
a “cluster” of 187 patients, among those defined as sep-
sis by the expert committee, with several characteristics
suggesting a more severe condition as well as better
microbiological confirmation compared to the rest of
the study population. According to standard definitions,
70% (n = 131) of these patients had severe sepsis withoutgroups defined by the expert consensus
cted without sepsis No infected P* value
n = 112 n = 148
1.5 (1–2, 112) 2 (1–4, 148) 0.001
6 (2–10, 112) 9 (5–14, 148) 0.001
6.9 (36.5 - 37, 102) 37 (36.5 - 37, 131) 0.064
83.5 (74–90, 106) 90 (79–108, 146) 0.001
18 (16–20, 15) 24 (20–36, 27) 0.001
13 (103–126, 106) 108 (95–130, 146) 0.001
0 (7500–11400, 112) 10400 (8000–13100, 147) 0.001
71 (60–81, 111) 77 (66–86, 147) 0.001
12 (11–14, 111) 13 (11–15, 147) 0.069
0.9 (0.8 – 1.3, 110) 0.9 (0.8 – 1.5, 146) 0.035
1.4 (1.0 – 1.8, 106) 1.7 (1.1 – 2.6, 143) 0.001
0.6 (0.4 – 0.8, 110) 0.7 (0.4 – 1.1, 142) 0.059
66 (315–407, 104) 307.5 (238 – 387, 142) 0.001
0.001
16 (14%) 43 (29%)
21 (19%) 13 (9%)
46 (41%) 15 (10%)
15 (13%) 24 (16%)
3 (3%) 25 (17%)
11 (10%) 28 (19%)
55 (49%) 63 (42%) 0.513
21 (19%) 27 (18%) 0.947
4 (3%) 27 (18%) 0.002
17 (15%) 17 (11%) 0.404
4 (3.6%) 19 (13%) 0.012
ntage). MAP, Mean Arterial Pressure, WBC, White Blood Cells, COPD, Chronic
Table 2 Diagnostic accuracy of CRP, DD and PCT for sepsis diagnosis at admission in the ER according to expert
consensus
Measurement 1 Measurement 2
Operating characteristics CRP DD PCT CRP DD PCT
(7.8 mg/dl) (1616 ng/ml) (0.30 ng/ml) (9.3 mg/dl) (1485 ng/ml) (0.27 ng/ml)
AUC – ROC 0.71 0.55 0.69 0.72 0.55 0.70
(0.67 – 0.74) (0.51 – 0.58) (0.65 – 0.72) (0.68 – 0.75) (0.51 – 0.58) (0.67 – 0.73)
Sensitivity 66.6% 51.4% 63.8% 68.9% 52.7% 67.2%
(0.62 – 0.71) (0.47 – 0.56) (0.59 – 0.68) (0.64 – 0.73) (0.48 – 0.57) (0.63 – 0.71)
Specificity 66.1% 51.6% 63.9% 68.7% 52.7% 66.4%
(0.60 – 0.72) (0.45 – 0.58) (0.58 – 0.70) (0.62 – 0.74) (0.46 – 0.59) (0.60 – 0.72)
LR + 1.97 1.06 1.77 2.20 1.12 2.00
(1.64 – 2.36) (0.91 – 1.24) (1.48 – 2.11) (1.81 – 2.68) (0.95 – 1.31) (1.65 – 2.41)
LR - 0.50 0.94 0.57 0.45 0.90 0.49
(0.44 – 0.58) (0.82 – 1.08) (0.49 – 0.65) (0.39 – 0.53) (0.78 – 1.03) (0.43 – 0.57)
Values between parentheses are cut-off points and 95% Confidence Interval, respectively. LR, Likelihood ratio.
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(Additional file 1). It was not possible to classify 46 pa-
tients because of missing values in any of CRP, DD or
PCT. Assuming this cluster of 187 patients as the new
prevalence of sepsis based on the LCA gold standard, the
ROC curve analysis identified new cut-off points for the
tests and suggesting a better discriminatory ability for
PCT with a value of 2 ng/ml (Table 4).
Discussion
Our results suggest that, under a “classical” definition of
sepsis, three typical biomarkers (CRP, PCT and DD) are
not capable enough to differentiate septic from non-
septic patients in the ER. Indeed, the kappa-statistic
measure for multi-rater agreement between experts for
this definition was 0.65 for sepsis-no sepsis and 0.73 for
infection with and without sepsis, which underlines the
limitations for clinical diagnosis in this condition. Using
another analytic approach, however, a higher cut-off
point for PCT (2 ng/ml) is able to identify and to ex-
clude a specific population more severely ill and with
better microbiological confirmation. To the best of our
knowledge, this is the first research that incorporates the
novel concept of a latent class to the process of diagno-
sis in sepsis.
The performance of a diagnostic test is judged by how
accurately the test result can identify a diseased or no dis-
eased person. The true disease status is the “gold stand-
ard” against which a test should be compared. However,
there are many conditions for which the definitive diagno-
sis is very difficult or expensive to establish. This is espe-
cially true for the diagnosis of a complex clinical condition
as sepsis, in which even within the construct of “systemic
response to infection” there is not a real “gold standard”
against which the diagnostic criteria can be calibrated[22,28,29]. Psychological and social sciences have a long
tradition in coping with primary study objects that are not
directly observable. Constructs such as intelligence, fear or
trust can only be measured indirectly. Inference proceeds
by modeling the relationship between observable and la-
tent variables in such a way that the parameters of interest
are estimable from the implied relations between observ-
able variables. When the unobservable variable is categor-
ical, the term latent class analysis (LCA) applies [6,7]. In
other words, LCA postulates the existence of an unob-
served categorical variable that divides the population of
interest in to classes. Members of the population with a
set of observed variables will respond differently depend-
ing on the latent class to which they belong. This tech-
nique can be applied to the problems related to diagnostic
testing, with the unobserved categorical variable being
“disease present” or “disease absent” [20].
Given the established interplay between inflammation
and coagulation in sepsis [14,30-32], it is reasonable to
characterize the host response to infection as a potential
diagnosis tool on the basis of three recognized markers of
these two cascades. The sensible mathematical model of
the latent diagnostic classification, using individuals’ values
of CRP, DD and PCT, was able to identify a subset of pa-
tients attended in the ER with suspicion of infection and
with clear differences in clinical status, microbiological
profile and 28-day mortality. Although this subset was
identified among those patients classified as sepsis by the
expert committee, there is not a unique clear cut-off in
any variable or test that may define the cluster specifically
as severe or bacteremic sepsis (Table 3). Furthermore,
among these three potential biomarkers, PCT proved to
be the most contributor to the “new” standard of more se-
vere disease but with a higher cut-off point than that usu-
ally suggested. Our main result, consequently, is that PCT
Table 3 Clinical characteristics at admission according to the LCA classification in clusters
Clinical Cluster 2 Cluster 1 Missing P*
valuecharacteristics n = 532 n = 187 n = 46
Age 51 (33–68, 532) 54 (37–70, 187) 39 (23–62, 46) 0.067
SOFA score 2 (1–3, 532) 4 (3–6, 187) 2 (1–3, 46) 0.001
APACHE II score 8 (5–13, 532) 13 (9–17,187) 8 (3–11, 46) 0.001
Temperature (°C) 37 (36.5-37.2, 489) 37 (36.7-38, 173) 37 (36.5-38, 43) 0.061
Heart rate 92 (80–108, 520) 100 (88–117, 182) 96 (81–114, 43) 0.001
Respiratory rate 20 (18–28, 90) 24 (20–29, 61) 26.5 (20–38.5, 12) 0.048
MAP 79 (68–90, 495) 72.5 (61–83, 180) 70.5 (60–77, 42) 0.001
WBC (cells/mm3) 11200 (8200–15100, 527) 13250 (9300–19300, 186) 13100 (9300–16700, 46) 0.005
Creatinin (mg/dl) 0.9 (0.8-1.3, 529) 1.4 (0.9-2.6, 185) 0.9 (0.7-1.6, 42) 0.001
Platelets (cells/mm3) 296000 237000 297000 0.001
(223000–391000, 525) (147000–301000, 183) (186000–404000, 46)
PaFi 324 (240–384, 515) 292 (190–355, 182) 332 (220–392, 41) 0.001
Lactic Acid (mmo/L) 1.6 (1.1-2.5, 518) 2.0 (1.3-3.1, 184) 1.8 (1.6-2.8, 41) 0.001
Suspected source of infection 0.001
Respiratory 129 (24%) 41 (22%) 9 (19%)
Urinary tract 76 (14%) 44 (23%) 7 (15%)
Skin and soft tissues 147 (28%) 20 (11%) 9 (19%)
Intra-abdominal 60 (11%) 27 (14%) 6 (13%)
Undetermined 47 (9%) 37 (20%) 10 (22%)
Others 73 (14%) 18 (10%) 5 (11%)
No comorbidity 237 (44%) 73 (39%) 28 (61%) 0.027
Diabetes 108 (20%) 33 (18%) 5 (11%) 0.250
COPD 69 (13%) 21 (11%) 4 (9%) 0.614
CRF 54 (10%) 32 (17%) 2 (4%) 0.011
28-day mortality rate 50 (9) 32 (17) 9 (19) 0.005
Blood culture requested 293 (55) 146 (78) 28 (61) 0.001
Positive blood culture 34 (12) 57 (39) 7 (25) 0.001
Procalcitonin (ng/ml) 0.21 (0.05 – 0.64) 15.07 (6.78 – 31.96) 0.64 (0.08 – 3.63) 0.0001
C reactive protein (mg/dl) 7 (2.3 – 15.65) 18.8 (8.3 – 25.9) 13.3 (8.3 – 21.7) 0.0001
D- dimer (ng/ml) 1406 (893 – 2329) 2883 (1386 – 5018) 1700 (1279 – 2398) 0.0001
The values are expressed as median (IQR, observations available) or number (percentage).
Missing = patients without information in any of PCT, CRP or DD; Cluster 1 = patients identified by LCA as a sepsis-like syndrome; Cluster 2 = the remaining of the
study population; MAP, Mean Arterial Pressure; WBC, White Blood Cells; PaFi, PaO2/FiO2; COPD, Chronic obstructive pulmonary disease; CRF, Chronic renal failure.
*Kruskal-Wallis for continuous variables and Chi-square for proportions.
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tic patients attending the ER. Such a finding was previ-
ously reported by Hausfater P et al. [33], whom studied
243 patients with body temperature of 38.5°C or greater
attended in the adult emergency department of an aca-
demic tertiary care hospital. They found, using standard
statistical methods, that PCT is an independent variable
that can predict whether a febrile episode has a bacterial
origin, and that at a threshold of 2 μg/l it is independ-
ently associated with critical illness. The coincidence
with our findings is remarkable, despite the fact that
their study population was extremely different: all thepatients consulted by a febrile episode, 29% of them
were immunocompromised, and only 81% were hospi-
talized in that consultation.
Needless to say, sepsis is not an illness but a syndrome
suspected mainly on clinical criteria, and the misdiag-
nosis of sepsis is associated with an extremely adverse
outcome. Consequently, we are not proposing a new
methodological approach for sepsis diagnosis. Instead,
we are identifying a new cut-off point for procalcitonin
to be able to detect more severely ill patients. This goal
was not achieved by the conventional clinical gold stand-
ard with expert consensus and, in this way, LCA is just
Table 4 Diagnostic accuracy of CRP, DD and PCT for




(12 mg/dl) (1848 ng/ml) (2.06 ng/ml)
AUC - ROC 0.71 0.73 0.95
(0.68 – 0.74) (0.69 – 0.76) (0.93 – 0.96)
Sensitivity 64.17% 65.24% 91.44%
(0.57 – 0.71) (0.58 – 0.72) (0.86 – 0.95)
Specificity 64.47% 65.23% 91.35%
(0.60 – 0.68) (0.61 – 0.69) (0.89 – 0.94)
LR + 1.81 1.88 10.81
(1.54 – 2.11) (1.60 – 2.19) (8.15 – 14.35)
LR - 0.56 0.53 0.09
(0.45 – 0.68) (0.43 – 0.66) (0.06 – 0.15)
Values between parentheses are cut-off points and 95% Confidence Interval,
respectively. LR, likelihood ratio.
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of sepsis diagnosis in the emergency room. The recent
literature is full of studies evaluating PCT for sepsis
diagnosis [16,17,34,35], but in the setting of the ER there
are less investigations testing its potential usefulness. In
a secondary care hospital of Finland, a population of 539
patients admitted to the ER with suspicion of infection
and with clinician’s order for blood cultures was studied
[16]. In assessing how the parameters differentiated all
sepsis patients (n = 358) from patients with no sepsis
(n = 181), AUC-ROC for PCT was 0.73 (95% CI 0.69 –
0.78), and PCT emerged as the best marker for severe
sepsis with an AUC-ROC = 0.77 (95% CI 0.71 – 0.84).
Riedel et al. evaluated the usefulness of PCT as a diag-
nostic predictive marker of bacteremia and sepsis in 259
patients who had blood cultures obtained in the ER of a
tertiary medical center in Baltimore [35]. In16 patients
there was evidence of bacteremia and 12(75%) patients
had a PCT level of more than 0.1 ng/ml. The PCT cut-
off value that maximizes the AUC-ROC (0.79) was
0.1475 ng/ml., but with sensitivity just in 75% and speci-
ficity of 79.8%. In a recent meta-analysis [36], Wacker C.
et al. analyzed 30 reports, although only two from ER,
accounting for 3244 patients. Bivariate analysis yielded
a mean sensitivity of 0.77 (95% CI = 0.72–0.81) and
specificity of 0.79 (95% CI = 0.74–0.84) and the area
under the receiver operating characteristic curve was
0.85 (95% CI = 0.81–0.88). The median cut-off for PCT
of the studies included was 1.1 ng/ml (IQR = 0.5–2.0)
and the absence of a threshold effect suggests that a cut-
off between 1.0 and 2.0 ng/ml, close to our findings, is
helpful for discrimination of patients with sepsis from
other inflammatory conditions. However, the studies had
substantial heterogeneity (I 2 = 96%, 95% CI = 94–99)
and none of the subgroups investigated like population,admission category, assay used, severity of disease, and
description and masking of the reference standard, could
account for that heterogeneity. They concluded that the
test may be helpful for diagnosis of sepsis in critically ill
patients, but it must be interpreted in context with in-
formation from careful medical history, physical examin-
ation and microbiological assessment.
Our study has several limitations. First, this is a single
center study in a specific geographic location with some
particularities from an epidemiological point of view
[2,37], which are obstacles for external validity. Moreover,
the pre-test probability of sepsis should be significantly
different in patients admitted to the ER and in patients ad-
mitted to ICU, even with the same clinical suspicion of
bacterial infection, and this is an acknowledged consider-
ation in the use and interpretation of any diagnostic test.
As we mentioned before, the clinical diagnostic “gold
standard” utilized here performed poorly, as the concord-
ance between experts was 0.65 for sepsis-no sepsis and
0.73 for infection with and without sepsis. This weakness,
indeed, underlines the limitations for clinical diagnosis in
this condition. On the other hand, LCA also has its limita-
tions as “gold” standard. Under this approach, sepsis is not
formally defined but rather is a mathematically defined en-
tity that does not necessarily correspond with a clinically
relevant status. Additionally, LCA modeling requires so-
phisticated analytic techniques and software, and the full
model or the hypothetical “true” state of disease cannot be
fully tested with the observed data. Finally, although blood
sampling was performed immediately after the patient was
admitted to the study, he/she could be in the ER at any
time within the last 24 hours before recruitment. This is
important because biomarker’s kinetic, notably PCT, and
their levels may varying considerably during 24 hours.
Conclusions
In summary, the “holy grail” of sepsis diagnosis is an evolv-
ing process and the fine exercise of clinical suspicion
should be complemented by appropriate laboratory test. In
this scenario, PCT emerges as an acceptable choice under-
scoring both microbiology and prognosis in selected pa-
tients. A higher level of PCT seems related more strongly
with these two components of the infectious phenomena.
Key messages
– CRP, PCT and DD are not capable enough to
differentiate septic from non-septic patients in the ER.
– A higher level of PCT seems related more strongly
with microbiology and prognosis, and discriminates
a selected group of patients with severe sepsis.
– Determination of the PCT level may be useful for
screening and prognosis of more-severely ill ER
patients.
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